X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hnc7 (12) 12
humans (12) 12
index medicus (12) 12
oncology (11) 11
female (9) 9
male (8) 8
original reports (8) 8
middle aged (7) 7
adult (6) 6
aged (5) 5
disease progression (5) 5
treatment outcome (5) 5
carcinoma, squamous cell - virology (4) 4
disease-free survival (4) 4
hnc6 (4) 4
recurrent (4) 4
squamous-cell carcinoma (4) 4
carcinoma (3) 3
carcinoma, squamous cell - mortality (3) 3
carcinoma, squamous cell - therapy (3) 3
endo7 (3) 3
head (3) 3
immunohistochemistry (3) 3
kaplan-meier estimate (3) 3
mutations (3) 3
oropharyngeal neoplasms - mortality (3) 3
prognosis (3) 3
proportional hazards models (3) 3
radiotherapy (3) 3
risk (3) 3
risk factors (3) 3
thyroid neoplasms - pathology (3) 3
aged, 80 and over (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
carcinoma, squamous cell - chemistry (2) 2
carcinoma, squamous cell - genetics (2) 2
carcinoma, squamous cell - pathology (2) 2
cisplatin - administration & dosage (2) 2
cyclin-dependent kinase inhibitor p16 (2) 2
expression (2) 2
head and neck neoplasms - therapy (2) 2
head and neck neoplasms - virology (2) 2
hnc1 (2) 2
hnc4 (2) 2
hnc5 (2) 2
kinases (2) 2
malignant-tumors (2) 2
neck-cancer (2) 2
neoplasm metastasis (2) 2
neoplasm staging (2) 2
oropharyngeal cancer (2) 2
oropharyngeal neoplasms - pathology (2) 2
oropharyngeal neoplasms - virology (2) 2
papillomavirus infections - complications (2) 2
piperidines - adverse effects (2) 2
plus cetuximab (2) 2
quinazolines - adverse effects (2) 2
randomized-trial (2) 2
ret protooncogene (2) 2
review (2) 2
review articles (2) 2
risk assessment (2) 2
smoking - adverse effects (2) 2
survival (2) 2
thyroid neoplasms - drug therapy (2) 2
thyroid neoplasms - genetics (2) 2
time factors (2) 2
to18 (2) 2
zd6474 (2) 2
2nd primary tumors (1) 1
activation (1) 1
adenoid cystic carcinoma (1) 1
administration, oral (1) 1
angiogenesis (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antigen-processing machinery (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - adverse effects (1) 1
antitumor immunity (1) 1
australia (1) 1
biochemical phenomena, metabolism, and nutrition (1) 1
biomarkers, tumor - analysis (1) 1
biomarkers, tumor - blood (1) 1
biomarkers, tumor - metabolism (1) 1
braf mutation (1) 1
brain (1) 1
brain neoplasms - pathology (1) 1
brain neoplasms - secondary (1) 1
calcitonin - blood (1) 1
cancer research (1) 1
carcinoembryonic antigen - blood (1) 1
carcinoma, adenoid cystic - drug therapy (1) 1
carcinoma, adenoid cystic - pathology (1) 1
carcinoma, medullary - drug therapy (1) 1
carcinoma, medullary - genetics (1) 1
carcinoma, medullary - metabolism (1) 1
carcinoma, medullary - mortality (1) 1
carcinoma, medullary - secondary (1) 1
carcinoma, neuroendocrine (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 10/2015, Volume 33, Issue 29, pp. 3293 - 3304
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2010, Volume 28, Issue 5, pp. 767 - 772
Purpose There is no effective therapy for patients with distant metastasis of medullary thyroid carcinoma (MTC). Activating mutations in the RET proto-oncogene... 
MALIGNANT-TUMORS | ANGIOGENESIS | ONCOLOGY | GROWTH | MUTATIONS | INHIBITOR | CARCINOMA | EXPRESSION | RET PROTOONCOGENE | ZD6474 | KINASES | Carcinoembryonic Antigen - blood | United States | Humans | Middle Aged | Carcinoma, Medullary - metabolism | Male | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Young Adult | Carcinoma, Medullary - drug therapy | Carcinoma, Medullary - secondary | Time Factors | Antineoplastic Agents - adverse effects | Germ-Line Mutation | Adult | Female | Quinazolines - administration & dosage | France | Proto-Oncogene Proteins c-ret - antagonists & inhibitors | Calcitonin - blood | Genetic Predisposition to Disease | Piperidines - administration & dosage | Thyroid Neoplasms - mortality | Carcinoma, Medullary - mortality | Drug Administration Schedule | Administration, Oral | Carcinoma, Medullary - genetics | Risk Factors | Kaplan-Meier Estimate | Treatment Outcome | Biomarkers, Tumor - blood | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Thyroid Neoplasms - genetics | Thyroid Neoplasms - drug therapy | Pedigree | Piperidines - adverse effects | Quinazolines - adverse effects | Aged | Proto-Oncogene Proteins c-ret - genetics | Thyroid Neoplasms - metabolism | Thyroid Neoplasms - pathology | Index Medicus | Hnc7 | Original Reports | Endo7 | To8
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2010, Volume 28, Issue 27, pp. 4142 - 4148
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.